News
Ayna joins Antag with extensive experience in obesity and clinical pharmacology. She most recently served as Senior Principal ...
Our writer shows how investing regularly in a SIPP account can lead to a £1m+ portfolio for savvy investors who start early ...
Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on ...
All three companies have had a tough time of it recently in the stock market. But in all three cases, our analysts think that ...
The Danish pharma giant's shares fell by up to 9% after Eli Lilly announced that its experimental daily pill may work just as ...
The FDA has received six adverse event reports connected to this specific lot of Ozempic (all submitted by Novo Nordisk), but ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Novo Nordisk (NVO), which develops weight-loss drugs, looks poised to perform well over the short term, Rebecca Walser, the ...
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
By Sukriti Gupta, Medha Singh and Nikhil Sharma (Reuters) -European shares ended slightly higher on Tuesday on the back of ...
Nordic stocks dropped Tuesday, with the OMX Nordic 40 Index declining 1.1%. Modern Times Group MTG AB Cl A posted the largest decline among large stocks during the session, dropping 9.2%, followed by ...
Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results